Friday, 29 April 2016


State-owned hydropower producer NHPC Ltd's Rs.2,700 crore share sale on Thursday managed to scrape through as oversubscription by institutional bidders made good for over 40% of retail portion which remained unbid for.

NHPC Ltd is currently trading at Rs. 20.8, down by Rs. 0.35 or 1.65% from its previous closing of Rs. 21.15 on the BSE. The scrip opened at Rs. 20.7 and has touched a high and low of Rs. 20.9 and Rs. 20.7 respectively. So far 8970434(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 23414.47 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 24.4 on 31-Mar-2016 and a 52 week low of Rs. 15.55 on 25-Aug-2015. Last one week high and low of the scrip stood at Rs. 23.25 and Rs. 21.05 respectively. The promoters holding in the company stood at 85.96 % while Institutions and Non-Institutions held 6.99 % and 7.05 % respectively. The stock is currently trading below its 50 DMA. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Jubilant FoodWorks Ltd stock was down by 2% at Rs.1170. Jubilant Consumer offloaded 3.6% stake in Jubilant FoodWorks, which operates Domino's Pizza and Dunkin Donuts chains, for over Rs.303 crore through an open market transaction, as per media reports. 

The scrip opened at Rs. 1196 and has touched a high and low of Rs. 1219.65 and Rs. 1170.05 respectively. So far 409789(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 7865.15 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1984 on 17-Jul-2015 and a 52 week low of Rs. 896.65 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 1347.65 and Rs. 1180.5 respectively.

The promoters holding in the company stood at 48.67 % while Institutions and Non-Institutions held 43.26 % and 8.07 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Steel Strips Wheels Ltd was up by 2% at Rs. 428. The company posted a net profit at Rs.18.49 crore for the quarter ended March 31, 2016. The net sales for the quarter was at Rs.308.8 crore for the quarter ended March 31, 2016. 

The scrip opened at Rs. 425 and has touched a high and low of Rs. 436.1 and Rs. 425 respectively. So far 42101(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 641.34 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 458 on 28-Dec-2015 and a 52 week low of Rs. 262.7 on 18-Jun-2015. Last one week high and low of the scrip stood at Rs. 423 and Rs. 387.5 respectively.

The promoters holding in the company stood at 59.17 % while Institutions and Non-Institutions held 0.56 % and 40.27 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

HCL Technologies dropped 4.4% to Rs.764.80 after the opening bell on Friday. The IT firm posted disappointing results for the third quarter ended March 31, 2016, missing street estimates. The company has posted a net profit of Rs.1675.4 crore for the quarter ended March 31, 2016 whereas the same was at Rs.1,564.7 crore for the quarter ended March 31, 2015. The company's total income is Rs.4855.7 crore for the quarter ended March 31, 2016 whereas the same was at Rs.4637.9 crore for the quarter ended March 31, 2015. The scrip opened at Rs. 795 and has touched a high and low of Rs. 795 and Rs. 759 respectively. So far 3659072(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 112837.76 crore. 

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1047.5 on 29-May-2015 and a 52 week low of Rs. 785.85 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 856 and Rs. 795.75 respectively. The promoters holding in the company stood at 60.38 % while Institutions and Non-Institutions held 32.63 % and 7 % respectively. The stock is currently trading below its 200 DMA. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Idea Cellular slid 4% to Rs.121.65 on Friday. Idea Cellular, the third largest telecom firm of the country, announced its financial results for the fourth quarter ended March 31, 2016 on April 28, 2016. Net profit of the company fell 24.7% to Rs.575.6 crore in Q4 compared with Rs.764.2 crore in Q3. Net revenue of the company stood at Rs.9,484 crore in Q4 as against Rs.9,009 crore in Q3.

The EBITDA margin was at 38.1% vs 34.7% qoq, while EBITDA surged 15.6% to Rs.3,616 crore vs Rs.3,128 crore qoq. Idea registered 1.5% growth in mobile data volume at 82.2 bn MB qoq, whereas the voice realised rate increased 4.4% at 33.3p/minute vs 31.8p/min qoq. The mobile data realised rate stood at 22.9p/MB vs 22.3p/MB qoq.

The scrip opened at Rs. 122.5 and has touched a high and low of Rs. 124.9 and Rs. 121.4 respectively. So far 3430555(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 45564.45 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 198.1 on 29-Apr-2015 and a 52 week low of Rs. 97.55 on 10-Feb-2016. Last one week high and low of the scrip stood at Rs. 128.05 and Rs. 115 respectively. The promoters holding in the company stood at 42.24 % while Institutions and Non-Institutions held 29.35 % and 28.41 % respectively.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Ambuja Cements Ltd, one of India’s leading cement manufacturers, has announced that the company has withdrawn the scheme of amalgamation, which was approved last year in July. “The Board at its meeting held on 27 July 2015 had approved the Scheme of Amalgamation of Dirk India (a wholly owned subsidiary) with the Company. The Board at its meeting held on 28 April 2016, decided not to pursue further with the scheme of amalgamation,” said the company in a statement.

Ambuja Cements Ltd is currently trading at Rs. 222, up by Rs. 1.75 or 0.79% from its previous closing of Rs. 220.25 on the BSE. The scrip opened at Rs. 222.25 and has touched a high and low of Rs. 224.4 and Rs. 221 respectively. So far 1199453(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 34180.54 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 256.5 on 15-Jul-2015 and a 52 week low of Rs. 185 on 29-Feb-2016. Last one week high and low of the scrip stood at Rs. 227.8 and Rs. 216.5 respectively. The promoters holding in the company stood at 50.28 % while Institutions and Non-Institutions held 40.36 % and 7.86 % respectively.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Tata Metaliks Ltd stock was higher by 12% at Rs.126. The Board of Directors of the Company at its meeting held on April 28, 2016, inter alia, has recommended a dividend of Rs. 8.50 per Non-Cumulative Redeemable Preference Shares of Rs. 100/- each and a dividend of Rs. 2/- per Equity Share of Rs. 10/- each for the year ended March 31, 2016.

The scrip opened at Rs. 120 and has touched a high and low of Rs. 129.1 and Rs. 119 respectively. So far 2233594(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 286.28 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 129.6 on 05-May-2015 and a 52 week low of Rs. 78 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 119.7 and Rs. 112 respectively.

The promoters holding in the company stood at 50.09 % while Institutions and Non-Institutions held 3.41 % and 46.5 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Nirlon Ltd stock was lower by 4% at Rs. 208. The company said its net loss widened to Rs.11.39 crore in March quarter. The scrip opened at Rs. 210.4 and has touched a high and low of Rs. 211.9 and Rs. 202.1 respectively. So far 48854(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 1960.11 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 221.5 on 28-Apr-2016 and a 52 week low of Rs. 153 on 12-Jun-2015. Last one week high and low of the scrip stood at Rs. 221.5 and Rs. 188.5 respectively. The promoters holding in the company stood at 71.59 % while Institutions and Non-Institutions held 7.7 % and 20.67 % respectively. The stock is currently trading above its 50 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Essel Propack Limited, a global leader in laminated plastic tubes catering to the FMCG & Pharma space, announced its financial results for the quarter ended March 31, 2016.

The company had divested flexible packaging business in July 2015. On a comparable basis excluding divested flexible packaging business:

Company’s consolidated FY16 net profit was up 32.5% at Rs. 176.7 crore as against Rs. 133.4 crore in FY15. Company’s consolidated FY16 revenue was up 3.0% at Rs. 2134.6 crore as against Rs. 2071.5 crore in FY15.

Company’s consolidated quarterly net profit was up 23.4% at Rs. 48.9 crore as against Rs. 39.6 crore in the corresponding quarter of last year. Consolidated quarterly revenue was up 2.8% at Rs. 561.4 crore as against Rs. 545.9 crore in the corresponding quarter of last year.

 Ashok Goel, Vice Chairman & Managing Director, Essel Propack Limited says“Yet another year of consistent and improved performance with profitable growth, creating value for stakeholders. Company is on track with its mission 20:20:20. Net profit continues to grow healthy with 5 year CAGR of 33%. Underlying revenue growth continues outside of India; India is now showing signs of growth, along with operational efficiencies and focus on non-oral care, the business is poised to sustain profitable growth.” 

Business Highlights for the Quarter ended March 31, 2016:

Europe, leading the revenue growth. EAP margin expansion thru increase in share of non-oral care revenue. Americas margin improve due to better efficiencies and scaling up the Colombia and Mexico to seize the market opportunity.

AMESA, domestic demand in India showing signs of growth. Net debt reduced by Rs. 201.4 Crores y-o-y to Rs. 644.1 Crores.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5%, the generic version of Epiduo Gel of Galderma Laboratories L.P.

According to IMS Health sales data for the 12 month period ending February 2016, the Epiduo® Gel market achieved annual sales of approximately $351.8 million*. Glenmark’s current portfolio consists of 112 products authorized for distribution in the U.S. marketplace and 58 ANDA’s pending approval with the U.S. FDA.

In addition to these internal filings,Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Granules India Ltd., a growing pharmaceutical manufacturing company, announced results for its fourth quarter ended 31st March, 2016. Financial Highlights for Q4 FY16 (Consolidated):-

Revenue: Rs. 373 Cr., an increase of 5% compared to Rs. 355 Cr. in Q4FY15
EBITDA: Rs. 80 Cr., an increase of 55% compared to Rs. 52 Cr. in Q4FY15
Net Profit: Rs. 33 Cr., an increase of 48% compared to Rs. 22 Cr. in Q4FY15

The Company‟s Board of Directors has proposed a final dividend of 20 paise /share of face value of Rs. 1each. “While we were strengthening our foundation last year, we simultaneously worked towards building a momentum for the future. We had a gentle top line growth but bottom line excelled with improved margins, validating our excellence in operational efficiency. Last year, we witnessed the commercialization of ourCRAMS business, ANDA approval for Ibuprofen Rx and the construction of a new capacity in addition to augmentation of R&D initiatives. This year and the year to come, we look forward to build a strong and agileGranules India‟, which will emerge as an efficient pharmaceutical manufacturing partner with a key focuson Research and Development.” said Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717